Expand AVR Menu
AVR MENU

AVR Latest Press Releases

-- February 26, 2026 --

Anteris Reports 2025 Financial Results and Provides Corporate Update Globe Newswire 6:00 PM

-- February 23, 2026 --

Anteris to Present at Healthcare Investor Conferences TD Cowen and Barclays Globe Newswire 6:30 AM

-- January 22, 2026 --

Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises Globe Newswire 4:02 PM
Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock Globe Newswire 4:01 PM

-- January 20, 2026 --

Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering Globe Newswire 10:53 PM
Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic Globe Newswire 4:01 PM

-- November 17, 2025 --

Anteris Technologies Presents Data from 100 DurAVR THV Patients at PCR London Valves Globe Newswire 6:00 AM

-- November 12, 2025 --

Anteris Announces Results for the Third Quarter of 2025 Globe Newswire 5:52 PM

-- November 3, 2025 --

FDA Approves Anteris's DurAVR THV Global Pivotal Trial (the "PARADIGM Trial") Globe Newswire 7:00 AM

-- October 28, 2025 --

Anteris DurAVR THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One Year Globe Newswire 6:08 PM

-- October 27, 2025 --

Anteris Technologies Announces First Patients Treated in DurAVR THV Global Pivotal Trial (the "PARADIGM Trial") Globe Newswire 5:43 PM
Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR THV to be Presented at TCT 2025 Globe Newswire 8:43 AM

-- October 15, 2025 --

Anteris Receives First European Regulatory Clearance to Commence DurAVR THV Global Pivotal Trial (the "PARADIGM Trial") Globe Newswire 9:18 AM
Market Data Delayed 15 Minutes